Free Trial Information
BioCentury | Jul 19, 2019
Preclinical News

July 19 Preclinical Quick Takes: Samumed's Alzheimer's candidate; plus a CRISPR RNA editing tool, new targets for fibrosis and pain

...tau pathology, inflammation Samumed LLC (San Diego, Calif.) reported in an Aging Cell paper that SM07883...
...1; TGFβ - Transforming growth factor β; XBP1 - X-box binding protein 1 Mary Romeo, Assistant Editor SM07883 Blade...
Read More
BioCentury | Aug 10, 2018
Financial News

Samumed raises $438M, plans host of trials

...clinical testing of another candidate, SM07883, to treat Alzheimer's disease. Samumed LLC, San Diego, Calif. Jennie Walters SM04554 SM04690 SM07883 Samumed...
Read More
BioCentury | Aug 6, 2018
Financial News

Samumed raises $438M, plans host of trials

...the company plans to start clinical testing of another candidate, SM07883, to treat Alzheimer's disease. Jennie Walters SM04690 SM07883 Samumed...
Read More
Items per page:
1 - 3 of 3